Related Content
February 13, 2018 — Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual ...
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomies ...
January 19, 2018 — Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter ...
There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or ...
January 3, 2018 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...
November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...
November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...
October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...
October 23, 2017 – The U.S. Food and Drug Administration (FDA) has cleared Abbott’s Confirm Rx Insertable Cardiac ...